eCommons

 

Alimentary pharmabiotics: common ground for academia with the food and pharmaceutical industries

dc.contributor.authorShanahan, Fergus
dc.date.accessioned2017-06-08T15:16:03Z
dc.date.available2017-06-08T15:16:03Z
dc.date.issued2010
dc.description.abstractDespite major technologic and conceptual advances in biology, new drug development in gastroenterology appears to be in decline. While large fortunes have been expended by the pharmaceutical industry in synthetic drug development, it is noteworthy that about half of the drugs approved by the FDA in the past twenty-five years have been derived from natural living material in the wider environment. Therefore, it seems logical and timely that the inner microenvironment of the alimentary tract might be another rich repository from which functional-food ingredients and new drugs can be mined. An alimentary “pharmabiotic” is the name that we have given to products derived from mining host-microbe interactions in the gut that have a proven health benefit.
dc.identifier.urihttps://hdl.handle.net/1813/51338
dc.language.isoen_US
dc.publisherNABC
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAgricultural biotechnology
dc.subjecthuman health
dc.subjectnutrition
dc.subjectfood production
dc.subjectdiet
dc.subjectfunctional foods
dc.subjectproduct choices
dc.subjectproduct claims
dc.subjectfood labeling
dc.subjectpharmabiotics
dc.subject
dc.titleAlimentary pharmabiotics: common ground for academia with the food and pharmaceutical industries
dc.typebook chapter

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nabc22_20_Shanahan.pdf
Size:
186.57 KB
Format:
Adobe Portable Document Format